Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Appeals Court Finds Link Between DPT Vaccine And Seizure

Executive Summary

Individuals seeking compensation for vaccine-related injuries have found it pays to litigate

You may also be interested in...

Vaccine Makers Ask Supreme Court To Assess Their Liability In Tort Claims

The U.S. Supreme Court is once again being asked to consider when personal injury suits are pre-empted by federal law. This time the focus is on vaccine-related injuries

A Legal Win For Vaccine Industry: Federal Court Finds No Link To Autism

After poring over more than 600 medical journal articles, dozens of expert reports, and testimony from a long line of witnesses, a federal court has concluded that there is no link between vaccines and autism in three test cases

Arbor Emphasizes Risks Of Its Own Product In Suit Against US FDA To Block Nymalize Generics

FDA concluded that original formulation of brain hemorrhage treatment was not discontinued for safety or effectiveness reasons, saying Arbor had other options to reduce risk of confusion between the new and original formulations. But the sponsor argues that withdrawal was part of FDA-approved risk mitigation plan.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts